Our decision to focus primarily on MMP-9 as a marker for targeted NF-κB signaling, rather than explicitly measuring IL-1beta, IL-6, and TNF-α, was influenced by MMP-9′s established utility as a marker of inflammation in superficial eye diseases [52,72,73]. Here, NFKB1 is linked to eye disorder.